CMS OKs Michigan’s Value-Based Payment Plan to Reduce Drug Costs

Drug Industry Daily
A A
CMS approved Michigan’s plan to allow its Medicaid program to negotiate “value-based” payment arrangements with drugmakers, linking drug costs to patient outcomes such as quality of life improvements, CMS Administrator Seema Verma announced Wednesday.

To View This Article:

Login

Subscribe To Drug Industry Daily